Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET)    Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register here    

SAVE THE DATES BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY ? * June 21, 2019 BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY? Blockchain  in Clinical Trials- How and Why Blockchain  and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? For the last 2 years, multiple initiatives are moving […]

Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]

Virtual Clinical Trials and Direct to Patient Shipments BeCRO has set up and coordinates, with the cabinet of Maggie De Block, FAMHP, FlandersBio, BioWin, Lifetech Brussels, BRAS and several top Pharma companies, a lobbying group on “Virtual Clinical trials and Direct to Patient Shipments”. This working group has conducted a survey on Direct to Patient […]

BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe Bruxelles Invest & Export invited BeCRo to present the attractivness of Brussels for clinical trials in the European Union, during the Brussels Days in Tokyo on May 18, 2016. This event was organized on the occasion of celebrating 150 years […]